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Macrophages  from  tumor-bearing  hosts  or  macrophages  incubated  with  tumor 
cells, tumor lysates, or tumor cell-conditioned medium  (TCM) 1 are often defective in 
their maturation (1, 2), chemotaxis in vitro or accumulation in vivo (3-14), spreading 
(15,  16), phagocytosis  (17-19), or antimicrobial activity  (20)  (reviewed in 21).  How- 
ever, few effects of tumor cells on macrophages have been described at the biochemical 
level.  In  particular,  tumor  cells  have  not  been  shown  to  suppress  the  ability  of 
macrophages to secrete substances cytotoxic for tumors. 
Among the macrophage secretory products with cytotoxic potential are the reactive 
oxygen  intermediates  (ROI),  including  superoxide  anion  (22,  23)  and  hydrogen 
peroxide  (24).  ROI  mediate  some  forms  of spontaneous  (25)  and  elicited  (26,  27) 
cytolysis  by  macrophages.  In  addition,  the  production of ROI  by  macrophages  is 
closely related to their inhibition of a number of intracellular pathogens (reviewed in 
28). Herein we report that TCM, as well as medium conditioned by certain nonma- 
lignant cells, selectively suppresses the ability of macrophages to secrete ROI. 
Materials and Methods 
Tumor  Cells.  P815  mastocytoma  and  PU5-1,  L1210,  EL-4, TLX9,  and  YAC  lymphomas 
were obtained  as  described  previously  (29-31)  and  passaged  as  ascites  in  the mouse  strains 
listed in Table I. GIF was a sarcoma arising spontaneously in the flank of a  (BALB/c ×  DBA/ 
2)F1  (CD2F~)  female mouse,  and  was  studied  in  its  first  in  vitro passage.  MC-6  mammary 
carcinoma, adenocarcinoma 755, and RC-2 renal adenocarcinoma were from the tumor bank 
of the Division of Cancer Treatment,  National Cancer Institute,  and were passaged as ascites 
in the mouse strains listed in Table I. J774 histiocytoma (32)  was maintained in spinner culture 
in Eagle's minimum essential medium, alpha variant, containing  100/xg/ml streptomycin and 
100  U/ml penicillin  (Grand  Island  Biological Company,  Grand  Island,  NY)  plus  10%  horse 
serum that had been heat inactivated at 56°C for 30 min (Flow Laboratories, Rockville, MD) 
(MEM-HS). The other tumors were maintained in stationary cultures in the same medium. 
Nonmalignant  Cells.  Granulosa  cells were  isolated  from  proestral  rat  Graafian  follicles as 
described (33).  LLC-PKx, a pig kidney epithelial cell line (34), was the gift of M. Sudol and E. 
Reich, The Rockefeller University. Rat fibroblast cultures were established by trypsinization of 
minced newborn Sprague-Dawley rats (Charles River Breeding Laboratories, Inc., Wilmington, 
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MA) and were used in their second passage.  Diploid skin fibroblasts (SK21)  from the American 
Type Culture Collection, Rockville, MD were used in their third passage.  Spleen cells  from 
(DBA/2 X BALB/c)Fx (D2CFI) mice were used after depleting adherent cells  during a  2-h 
incubation in plastic tissue culture flasks. Erythrocytes were obtained from the axillary vessels 
of D2CF1 mice and collected in heparin (20 U/ml). The above were all cultured in MEM-HS. 
Tests for Mycoplasma and Viruses.  Cytocentrifuged cells were fixed and stained for 10 min in 
1 #g/ml bisbenzimidazol in methanol (Aldrich Chemical Co., Milwaukee, WI) (35). The slides 
werre examined in a  fluorescence microscope with a  366  _+  11  nm excitation filter and an 
emission filter with a 460-nm cutoff (Carl Zeiss, Inc., New York)  to detect cytoplasmic DNA 
indicative of mycoplasma. In addition, antibody to  mycoplasma was sought  in the sera of 
tumor-bearing mice by Microbiological Associates,  Walkersville, MD.  Before  and 4  d  after 
injection of 106 P815 ascitic or cultured cells, the sera of four Nelson-Collins Swiss (NCS)  mice 
were tested for lactate dehydrogenase, using a commercial assay kit (Sigma Chemical Co., St. 
Louis,  MO).  Elevations in  this  enzyme activity are  characteristic  of infection by  lactate 
dehydrogenase-elevating virus (36). Sera of tumor-bearing mice were tested by the Laboratory 
Animal Research  Center, The  Rockefeller University, for  complement-fixing antibodies to 
Sendai, ectromelia, mouse hepatitis, lymphocytic choriomeningitis, and mouse adenoviruses, 
and for hemagglutination-inhibiting  antibodies to pneumonia virus, polyoma, minute virus, K- 
virus  (newborn mouse pneumonitis virus), Theiler's encephalomyelitis (GDVII)  virus, and 
reovirus type 3. 
Conditioned Media.  TCM was collected from 48-h cultures of tumor cells in MEM-HS, with 
a  final cell  density of ~1.5  X  106/ml  and a  final viability of >90%.  Cells were removed by 
centrifugation at 500 g for  15 rain, and the supernatant was dialyzed in Spectra/Por 6 tubing 
(1,000-dahon cutoff)  (Spectrum Medical Industries, Inc., Los Angeles, CA)  for 24 h  at 4°C 
against 20-50 vol of MEM. The TCM could be stored for >1 mo at 4°C or >3 mo at -20°C. 
Alternatively, 5  X  106 cells/ml were  incubated in MEM-HS  for  10  h  and the supernatant 
dialyzed as above. Conditioned medium was also collected from adherent cells in monolayers 
that were ~75% confluent in 25-cm  2 flasks containing 10 ml MEM-HS. To prepare lympho- 
kines, D2CF1 spleen cells were incubated at  l0  s cells/ml in RMPI  1640 containing 10% fetal 
bovine serum, pyruvate, glutamine, nonessential amino acids,  2-mercaptoethanol, and anti- 
biotics as described (31). Concanavalin  A (Con A) (3/~g/ml) (Sigma Chemical Co.) was added 
at the beginning  or the end of the 48-h incubation, or was omitted. 
Macrophages.  Mice >6 wk old of either sex  and of the following strains were  used with 
equivalent results:  CD2F1  (Simonsen Laboratories, Gilroy, CA), D2CF1,  C57BL/6  (Trudeau 
Institute, Saranac Lake, NY), NCS  (The Rockefeller University), and ICR (Taconic Farms, 
Germantown, NY). Resident cells were collected from the peritoneal cavities of untreated mice, 
or peritoneal cells were collected 12-20 d after intraperitoneal injection of 7 ×  106 viable bacilli 
Calmette-Gufirin (BCG)  (type  1011, Trudeau Institute) in 0.1  ml 0.9% NaCI;  4-6  d  after 
intraperitoneal injection of  1 ml of 6%  sodium caseinate (Lot  ABX,  Eastman Kodak Co., 
Rochester, NY)  in 0.9% NaCI; or 5 d after intraper!toneal injection of 1 ml of 10% proteose 
peptone  (Difco  Laboratories,  Detroit,  MI)  in 0.9% NaC1. Differential counts of these  cell 
populations have been reported previously (24, 25, 29). The cells were suspended in MEM-HS, 
and  1 ml containing 2 ×  10  6 ceils was dispensed to each  16-mm Diam well of Cluster trays 
(Costar,  Data  Packaging, Cambridge, MA)  on which a  13-ram  Diam ethanol-cleaned glass 
coverslip (Clay Adams, Inc., New York)  had been placed. 4-6 h later, nonadherent cells were 
removed, and the medium was replaced with MEM-HS or various dilutions of dialyzed TCM 
in MEM-HS. Where indicated, peritoneal cells were suspended directly in TCM before plating, 
and nonadherent cells were left in the cultures. 
H202 Release.  After various periods of incubation in test or control media, coverslips with 
adherent peritoneal cells were rinsed by agitation in three beakers of 0.9% NaC1. Excess fluid 
was  removed with  absorbent  paper,  and  the  coverslips  were  placed  in  Cluster  tray  wells 
containing  1.5  ml  Krebs-Ringer phosphate  buffer  with  5.5  mM  glucose,  pH  7.35 7.40, 
formulated as described (24). Each well also contained 15 nmol scopoletin, 1.5 purpurogallin 
units (10 #g)  horseradish peroxidase (Sigma Chemical Co.),  1 mM NaNa to inhibit catalase, 
and 150 ng phorbol myristate acetate (PMA)  (Consolidated Midlands Co., Brewster,  NY).  In 
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to 50% fresh mouse serum at 37°C, washed by centrifugation, and added to the cultures. In this 
case, the plates were centrifuged at 500 g for 3 min at 4°C, and the coverslips were transferred 
to fresh  wells containing the assay mixture described above but with PMA omitted. Assays 
were initiated by floating the trays in a 37°C water bath. The medium was collected 60 min 
later, and fluorescence was determined as described (37). Control media were collected from 
wells  lacking cells.  In preliminary experiments, the amount of H202 detected from cells not 
given PMA or zymosan was <1% of the stimulated values. Separate coverslips were rinsed as 
above and used to determine adherent cell protein by the method of Lowry et al.  (38) using 
bovine serum albumin as a standard. Results are expressed  as the mean +  SEM for nmol H202 
released from  triplicate coverslips,  divided by the mean mg protein on triplicate coverslips 
incubated under identical conditions. 
Other Assays.  Superoxide anion secretion was assayed by the superoxide dismutase-inhibit- 
able reduction of ferricytoehrome c (23), using macrophages stimulated with PMA or zymosan 
as described above. Secretion of arachidonic acid and its metabolites was determined from the 
radioactivity of media of zymosan-stimulated macrophages that had been labeled to constant 
specific activity with [3H]-arachidonic acid, as described in detail (39). Lysozyme was measured 
in the media of 48-h macrophage cultures by recording the decrease in absorbance at 600 nm 
of a  suspension of 100/zg/ml Micrococcus luteus (Miles Laboratories, Elkhart,  IN)  in 0.06  M 
sodium phosphate buffer in 0.9% NaCI at room temperature, compared with a hen egg white 
lysozyme standard (Worthington Biochemical Corp., Freehold, NJ)  (40). 
To measure plasminogen activator, macrophages were incubated for 48 h in TCM or MEM- 
HS, washed extensively, and incubated an additional 48 h in serum-free MEM. Aliquots of the 
medium were added to plates coated with l~I-fibrin (41) with and without purified human 
plasminogen (a kind gift of M. Sudol, The Rockefeller University) and soluble radioactivity 
was determined 1 h later. The activity of plasminogen activator was calculated by comparison 
to a urokinase standard. 
To compare DNA synthesis in TCM and MEM-HS, 5 ×  106 macrophages were incubated 
in 35-mm plastic petri dishes  in 2.5 ml of either medium. At 24 h,  10/~Ci [ H]thymidine (2.0 
Ci/mmol, New  England Nuclear,  Boston,  MA)  was  added.  At  48  h,  the  monolayers were 
washed in phosphate-buffered saline and scraped with a rubber spatula. Cells were sedimented 
at 8,000 g, resuspended in lysis solution (9.5 M  urea, 5% 2-mercaptoethanol, 2% NP-40), and 
frozen and thawed.  DNA was precipitated with  10%  trichloroacetic acid  (TCA) containing 
0.1% unlabeled thymidine and washed with the same solution on 0.4-~m pore filters (Millipore 
Corp., Bedford,  MA). The dried filters were used for scintillation counting. 
To compare protein synthesis by macrophages in TCM and MEM-HS, 48-h cultures like 
those above were pulsed for  the last 6 h  with  100/~Ci  [3SS]methionine  (450 Ci/mmol, New 
England Nuclear), and the monolayers were washed, scraped, and lysed as above. Aliquots of 
the lysate were applied to filters and boiled in 10% TCA with 0.1% unlabeled methionine for 
5 min, soaked in cold 5% TCA, and washed in cold 98% ethanol. The dried filters were used for 
scintillation counting. The content of glutathione (42) and the specific activity of glutathione 
reductase (43), glutathione peroxidase (44), catalase (45), and guaiacol peroxidase (46) were 
measured as described. Phagocytosis was measured using 14C-acetyl starch granules in 20-rain 
uptake periods, as described (47). 
Results 
Suppression of Macrophage H202-releasing Capacity by Conditioned Media.  In preliminary 
experiments, co-culture of BCG- or caseinate-activated macrophages for 24-48 h  in a 
2:1 ratio with P815 mastocytoma, P388 lymphoma, or TLX9 lymphoma cells ablated 
detectable H202 release when the macrophage monolayers were subsequently washed 
to  remove tumor ceils and  then challenged with  the  secretagogue,  PMA  (48).  To 
eliminate the possibility that tumor cells exerted this effect by exhausting the medium, 
subsequent experiments used TCM  dialyzed against fresh MEM. As shown in Table 
I, conditioned medium from  11  of 11  tumors tested markedly suppressed the H202  o 
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TABLE  I 
Effect of Conditioned Media on 11202 Release by Caseinate-activated  Macrophages 
Negative tests for  Percent 
Medium* conditioned by  Species and strain  contamination  inhibition:~ 
P815 mastocytoma  Mouse, D2CF, or  §, [I, ¶, **  97.9 
CD2F1 
PU5-1 lymphoma  Mouse, BALB/c  100.0 
L1210 lymphoma  Mouse, CD2F1  92.4 
EL-4 lymphoma  Mouse, C57BL/6  96.2 
TLX9 lymphoma  Mouse, C57BL/6  §, :~$  68.2 
YAC lymphoma  Mouse, A/Sn  §  99.0 
GIF sarcoma  Mouse, CD2F1  89.6 
J774 histiocytoma  Mouse, BALB/c  67.5 
MC-6 mammary carcinoma  Mouse, BALB/c  60.5 
Adenocarcinoma 755  Mouse, C57BL/6  94.9 
Renal adenocarcinoma 2  Mouse, CD2F1  98.5 
Erythrocytes  Mouse, D2CF~  9.0 
Peritoneal macrophages  Mouse, D2CF1  25.3 
Splenic lymphocytes  Mouse, D2CF1  27.2 
Diploid skin fibroblasts  Human  §  64.8 
Fibroblasts (from newborns)  Rat  75.1 
LLC-PK~ cells, epithelial  Pig  99.1 
kidney 
Graafian  follicle  granulosa  Rat  100.0 
cells 
*  Medium was conditioned for 48 h  as described in Materials and Methods and dialyzed against 20-50 
vol of MEM before use. 
:~  Macrophages from 2 X  106 caseinate-elicited peritoneal cells were incubated in conditioned media for 
48  h,  washed,  and  challenged  with  PMA  to  measure  H202  release over 60  rain  in  comparison  to 
macrophages incubated for 48 h in MEM-HS alone. Data are from five experiments, in which values for 
the control macrophages averaged 463 nmol H202/mg cell protein/60 min. 
§  Tested for mycoplasma contamination by bisbenzimidazol staining. 
U  Tested for lactate dehydrogenase-elevating virus. 
¶  Tested for Sendai virus. 
** Tested for pneumonia  virus,  reovirus 3,  Theiler's encephalomyelitis virus,  polyoma virus, ectromelia 
virus, murine hepatitis virus, murine adenovirus, lymphocytic choriomeningitis virus, newborn mouse 
pneumonitis virus, minute virus, and mycoplasma by serologic techniques (see Materials and Methods). 
:~:~ Negative for all organisms listed above (**), except positive for minute virus of mice. 
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FIG.  l.  Influence of tumor cell  number and incubation  time on potency of TCM.  Medium  was 
conditioned for 10,  15, or 25 h by P815  cells  initially cultured at 5 X  10s/m]  (A),  ]  X  10s/m]  (&), 
5  X  106/ml  (O),  or  1  X  10T/ml  (O).  The  media  were  dialyzed  and  added  at  the  indicated 
concentrations (%, vol/vo])  to adherent cells  from  2 X  10  s caseinate-elicited  peritoneal cells.  48 h 
later, TCM was washed off and H202 released measured in response to PMA. Means and SEM of 
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also with BCG-activated macrophages, and gave the same results as with the caseinate- 
elicited  cells  (data  not  shown).  The  tumors  were  syngeneic  or  allogeneic  to  the 
macrophages,  adherent  or  nonadherent,  lymphocytic,  histiocytic,  or  fibroblastic, 
carcinogen-induced, x-ray induced, or spontaneously arising, and were tested after in 
vivo  or  in  vitro  passages  numbering  from  one  to  many  hundreds.  Testing  for 
mycoplasma,  lactate  dehydrogenase-elevating virus,  and  other murine  viruses  was 
negative  with  P815  mastocytoma,  the  tumor  chosen  for  the  most  of the  further 
experiments. 
As shown in Table I, there was little suppression of H202-releasing capacity after 
48 h  incubation of macrophages in medium conditioned by erythrocytes or macro- 
phages. Spleen cell-conditioned medium was variably suppressive. Diploid fibroblasts 
and ovarian follicular cells in early passage and  a  long-passaged porcine epithelial 
cell line had clear-cut suppressive effects. 
Kinetics of Conditioning of Medium by P815 Cells and Dose Dependence of the TCM.  To 
quantify the conditioning of medium by P815 cells, different numbers of tumor cells 
ranging  from  5  ×  10n/ml  to  1  ×  10V/ml  were  cultured  in  MEM-HS  for periods 
varying from 10 to 25 h. The TCM were then dialyzed against fresh MEM and added 
in  dilutions  to  caseinate-activated  macrophages.  48  h  later,  the  monolayers were 
washed to remove TCM, and their H202-releasing capacity was tested upon challenge 
with PMA. As shown in Fig.  1, the suppressive potency of TCM depended both on 
the number of tumor cells per volume of medium and the duration of the tumor cell 
culture.  For  example,  100%  suppression  of macrophage  H202-releasing  capacity 
followed a 48 h exposure to 50% (vol/vol) of dialyzed medium conditioned by 5 X  106 
P815  cells/ml  for  10  h,  or by 5  ×  105  P815  cells/ml  for 25  h.  Dialyzed medium 
conditioned by 5 X  106 P815 cells/ml for 10 h was designated P-10h and used in most 
of the subsequent experiments. In the experiment indicated in Fig. 1, 50% suppression 
of H202 release followed incubation of macrophages for 48 h  in  13% of P-10h. 
Kinetics of Suppression of H202 Release by TCM.  100% P-10h was added to unsepa- 
rated BCG-elicited peritoneal cells  (Fig.  2 A), adherent peritoneal cells from BCG- 
elicited exudates (Fig. 2 B), or adherent, caseinate-elicited peritoneal cells (Fig. 2 C). 
In each case, H202 release was suppressed nearly completely. However, BCG-elicited 
macrophages lost H202-releasing capacity spontaneously over the same time period, 
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FIG.  2.  Time course of suppression of H202 release by TCM. TCM was prepared by incubating 
5 X  106 P815 cells/ml for 10 h and dialyzing the supernatant. Cells cultured in TCM (0) or MEM- 
HS alone (O) were (A)  from BCG-elicited peritoneal exudates; (B) as in (A) with nonadherent cells 
removedbefore  addition  of test  media;  or  (C)  from caseinate-elicited  peritoneal  exudates, with 
nonadherent cells removed. H202 release in response to PMA was tested after the indicated periods 
of incubation. Means and SEM of triplicates are shown. 950  SUPPRESSION  OF  MACROPHAGE  H202  RELEASE 
as reported earlier with this (49)  and other (50)  microbial vaccines. TCM accelerated 
this decline. In contrast, caseinate-activated macrophages retained or even increased 
their  H202-releasing capacity during 48 h  in  vitro, so that  the suppressive effect of 
TCM  was  much  more evident.  With  the  latter  macrophages,  50%  suppression  of 
H202-releasing capacity was obtained by 18 h  of exposure to P-10h. 
In  an  earlier  report,  caseinate-elicited  guinea  pig  macrophages  in  monolayer 
cultures required 2-3 d  to respond to the lymphokine, macrophage-activating factor 
(MAF). However, the period of exposure to MAF could be shortened to  1-2 d  if the 
macrophages had been in culture  for  1-2 d  before MAF was added  (51).  Similarly, 
the 48-h period required for complete suppression of HzOz release by TCM could be 
caused by prolonged interaction of TCM with macrophages or the gradual acquisition 
by macrophages of the capacity to respond quickly to TCM. To investigate the latter 
possibility,  macrophages  were  incubated  with  P-10h  throughout  the  48-h  culture 
period, or only for the final 24, 6 or  1 h. Only macrophages exposed to TCM for 48 
h showed complete suppression (data not shown). 
Dose  Dependence  and  Reversibility  of  Effect  of  Media  Conditioned  by  Nonmalignant 
Cells.  The suppressive activity in medium conditioned  by newborn rat  fibroblasts, 
human skin fibroblasts, and mouse spleen cells appeared to be present in 3.5- to 7-fold 
lower  concentrations  than  that  in  P815  TCM,  judging  by  the  concentration  of 
conditioned  medium  required  to  cause  50%  inhibition  of H202  release  (Fig.  3 A). 
Moreover, within  48  h  of its  removal, the  effect of nonmalignant  cell-conditioned 
medium was completely reversed, whereas the effect of TCM persisted (Fig. 3 B). 
Reversibility of Suppression by TCM.  To determine whether the suppressive effect of 
TCM  was  reversible,  caseinate-activated  macrophages  were  incubated  in  various 
dilutions of P-10h for 48 h. As usual, HzOz-releasing capacity was suppressed at that 
time in a dose-dependent  manner. The remaining cultures were then placed in fresh 
MEM-HS and tested at intervals over the next 6 d. As shown in Fig. 4, the suppressive 
effect of TCM  persisted  for 4  d  after its  removal.  By  the  8th  d  of culture,  H2Oz- 
releasing capacity of macrophages which were last exposed to TCM 6 d  previously, 
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Fro.  3.  (A)  Dose-dependent  effects  of media  conditioned  by  different  cells.  H202  release  was 
measured 48 h after incubation of easeinate-activated macrophages in the indicated concentrations 
of dialyzed media conditioned by P815  cells at 5 x  106/ml  for 10 h  (O) or 1 X  106 for 48 h  (Q);  by 
newborn rat fibroblasts (A) or mouse spleen cells  (F'l) at 5 X  106/ml  for 10 h; or by a  75% confluent 
monolayer of human skin fibroblasts at 0.4 ml/cm  z for 48 h (A). Means and SEM for triplicates are 
indicated  for  data  from  three  experiments.  (B)  Rapid  reversal  of suppressive effect  of media 
conditioned by spleen cells  (F'l) and newborn rat fibroblasts (A) but not by P815  cells  (O). After 48 
h incubation in the conditioned media at the indicated concentrations, the coverslips were washed 
and placed in MEM-HS for an additional  48  h  before H202 release was measured in response to 
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FIG. 4.  Delayed reversal of suppression after removing TCM. Caseinate-activated macrophages 
were incubated for 48 h in TCM (0) or MEM-HS (O), washed, and placed in fresh MEM-HS 
alone. H202 release was measured at 2-d intervals. 
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increased to equal that of cells never exposed to TCM. Thus, the effect of TCM was 
reversible, but only after a long delay. 
Effect of Lymphokines on Suppression of Hz02 Release by TCM.  Resident or inflamma- 
tory mouse peritoneal  macrophages can  be  induced  by lymphokines to exhibit  an 
enhanced capacity to release  H20~  (50,  52-54).  It was of interest  to learn  whether 
lymphokines would prevent the suppressive effect of TCM on H202 release or hasten 
the reversal of this suppression after removal of TCM. As shown in Table II, a  2-d 
incubation  in  10%  Con A-induced lymphocyte supernatant  plus  TCM  resulted  in 
suppression. A 2-d incubation in lymphokines in the absence of TCM did not reverse 
the suppression  seen  with  macrophages exposed  to TCM  during the  previous  2  d. 
This was  the  case whether caseinate-activated  or proteose peptone-elicited  macro- 
phages were used. The potency of the lymphokine preparation was confirmed by its 
ability to triple the H202-releasing capacity of the proteose peptone-elicited macro- 
phages (Table II). 
Effect of TCM on Secretion of ROI Triggered by PMA or Zymosan.  TCM was unlikely to 
suppress  apparent  PMA-induced H20~ release  by interference with  the binding of 
PMA  to  the  macrophages or the  reaction  of H202  with  the  fluorescent  indicator, 
because  the  macrophages were  removed from TCM  and  washed  before the  assay. 
Nonetheless, to exclude these possibilities,  we used a  different stimulus for secretion 
and a  different assay for detection of ROI. As shown in Table III, TCM suppressed 
O~- release from macrophages, as markedly as it suppressed H202 release. Moreover, 
the release of both substances was suppressed by TCM when zymosan was used as the 
stimulus  instead  of PMA.  However,  the  degree of suppression  using zymosan was 
usually less than with PMA. The reason for this difference is not known. 
HeOe-Catabolizing Pathways in TCM-treated Macrophages.  Suppression of HzOz release 
from TCM-treated macrophages could result either from decreased synthesis of H202 
or from its increased catabolism. To investigate the latter possibility, we measured the 
specific activity or specific content of the known major H202-catabolizing moieties in 
mononuclear phagocytes, namely, catalase,  glutathione peroxidase,  glutathione re- 
ductase, glutathione, and myeloperoxidase. As shown in Table IV, 48 h  of exposure 
to P-10h resulted in decreases in the activity of catalase, glutathione peroxidase, and 
the content of glutathione, and no changes in the other factors. Thus, no increase in 952  SUPPRESSION  OF  MACROPHAGE  H202  RELEASE 
TABLE  II 
Effect  of Lyrnphokines on Suppression of H202 Release by TCM* 
Lymphocyte 
supernatant 
Caseinate-elicited  macrophages 
incubated days 0  2 with: 
MEM-HS  P-10h 
Proteose peptone-elicited macro- 
phages incubated days 0-2 with: 
MEM-HS  P-10h 
Added on days 0  2: 
Con A stimulated$  379 --- 32§  147 +- 41  NDII 
Con A control¶  398 +  81  144 _  66 
No Con A added**  415 --- 36  112 +- 47 
None:~:~  381  ---  15  91  +- 30 
Added on days 2  4: 
Con A stimulated  368 -+ 24§§  47 +- 3  126 +  29§§ 
Con A control  245 +-- 5  48 +- 7  51  +- 20 
No Con A added  ND  38 ±  4 
None  416  -  20  23 +- 3  45 +  5 
8.2--.-0 
82+0 
7.5+  1 
7.4+  1 
*  Macrophages from 2 ×  106 peritoneal cells were incubated for 48 h  in 90% MEM-HS or 90% dialyzed 
P-10h,  plus 10% of the indicated  lymphocyte supernatant, washed, and tested for H202 release on day 
2  (upper  half of table).  Alternatively,  10%  additional  MEM-HS  was  added  on  day  0  instead  of 
lymphocyte supernatant, and on day 2, all  media were replaced with 90%  MEM-HS plus  10% of the 
indicated lymphocyte supernatant, until testing for H20.* release on day 4 (lower half of table). 
:~  Spleen cells were incubated 48 h in enriched RPMI-fetal bovine serum. Con A (3/~g/ml) was added at 
the start of the incubation. The supernatant was dialyzed against MEM and added to the macrophage 
cultures at a final concentration of 10%. 
§  H202, nmol/mg cell protein per 60 min, assayed on day 2. Mean --- SEM for three experiments, each in 
duplicate or triplicate. 
II  Not done. 
¶  Prepared as in (:~), except that Con A was added at the end of the 48 h incubation of lymphocytes. 
** Prepared as in (:~), except that no Con A was added. 
:~:~ Macrophage cultures supplemented with an additional  10% MEM-HS instead of lymphocyte superna- 
rant. 
§§ H2Oz, nmol/mg cell protein per 60 rain, assayed on day 4. Mean --- SEM from a single experiment. 
TABLE  III 
Effect of TCM on Release of Hydrogen Peroxide and Superoxide from Caseinate-activated Macrophages * 
Experi-  Medium 
ment 
Hydrogen peroxides  Superoxide:~ 
PMA§  Zymosanll  PMA  Zymosan 
A  MEM-HS  267  426  69  22 
TCM¶  4.7  (98)**  112  (74)  8.8  (87)  12  (45) 
B  MEM-HS  374  485  138  36 
TCM  15  (96)  169 (65)  19  (86)  28 (22) 
C  MEM-HS  355  405  37  54 
TCM  28  (92)  239  (41)  8.7  (76)  17  (69) 
D  MEM-HS  518  447  ND:~:~  ND 
TCM  38 (93)  280  (37) 
*  Adherent cells from 2 ×  l06 peritoneal cells tested after 48 h incubation. 
:~  nmol/mg cell protein per 60 min (mean of duplicates for HzO2; single determinations for O½-). 
§  PMA  100 ng/ml. 
H  Opsonized with fresh mouse serum (see Materials and Methods). 2 ×  10  7 particles per coverslip. 
¶  Medium conditioned for 48 h by P815  cells and dialyzed before use. 
** Percent inhibition. 
~:~ Not done. ANNA  SZURO-SUDOL AND  CARL  F.  NATHAN 
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Effect of TCM on HeO~-Catabolizing Activities of Macrophages* 
953 
Assay 
Incubation medium 
MEM-HS  P- 1  Oh 
Catalase~  2.00 x  10  -a  1.66 x  10  -3 
Glutathione§  13.2  6.8 
Glutathione reductase][  55.6  50.7 
Glutathione peroxidase][  354  162 
Myeloperoxidase¶  0  0 
* Caseinate-activated macrophages were incubated for 48 h in the indicated media before assay. Data from 
one of two similar experiments. 
~: Baudhuin U/mg cell protein. 
§ nmol of the tripeptide/mg cell protein. 
II nmol NADPH oxidized/rag cell protein/min. 
¶ Guaiacol  and H20~ as substrates. 
Fro.  5.  Phase-contrast photomicrographs (× 1,340) of caseinate-activated macrophages incubated 
for 48 h  in TCM  (A, C) or MEM-HS (B, D), with (A, B)  or without (C, D)  20-min  exposure to 
starch granules from the seeds of Amaranthus caudatus. 
H202-catabolizing pathways could be found to account for diminished H202 release 
after exposure to TCM. 
Effect  of  TCM on  Macrophage  Morphology  and  Phagocytosis.  The  reversibility of its 
effects suggested that  TCM  was  not  toxic  to  macrophages.  However,  to  assess the 954  SUPPRESSION OF MACROPHAGE  H202 RELEASE 
possibility of toxicity more directly, we compared  the  ability of TCM-treated and 
control macrophages  to  phagocytize radiolabeled starch  granules under conditions 
shown to  maximize the  detection of differences in phagocytic rates  among various 
macrophage  populations  (47).  TCM-treated  macrophages  were  avidly  phagocytic 
(Fig. 5 A), ingesting 4.5  +  0.0 mg starch/mg cell protein in 20 min, compared with 
5.4  +  0.2  mg starch/mg cell protein in 20  min for control macrophages  (Fig.  5 B). 
TCM-treated macrophages appeared morphologically normal by phase-contrast mi- 
croscopy  (Fig.  5 C).  They tended to be more spread out on glass than the controls 
(Fig. 5 D), an effect noted by others culturing macrophages with tumor cells (55)  or 
tumor-induced ascites (56). 
Effect  of TCM on  Macrophage  DNA  and  Protein  Synthesis.  We  next  addressed  the 
question of whether TCM  had a  selective effect on secretion of ROI, or whether it 
suppressed macrophage metabolism in general. We focused first on DNA and protein 
synthesis because of the observation that the adherent cell protein content of macro- 
phage  monolayers incubated for  48  h  in TCM  averaged  30.5  +  2.7 /xg, compared 
with  20.4  +  1.5  /lg  for  cells  incubated in  MEM-HS  alone  (mean  +  SEM  for  25 
experiments). This could be due to  increased adherence of the  TCM-treated cells. 
Alternatively, TCM  might enhance cell replication or net protein synthesis per cell. 
As shown in Table V, TCM-treated, caseinate-activated macrophages incorporated 
TABLE V 
Effect of TCM on DNA and Protein Synthesis 
Precursor 
Incubation medium 
MEM-HS  TCM* 
cpm/mg protein 
[3H]Thymidine:~  (31 +  19) ×  103  (12 + 7) ×  10  a 
[a~S]Methionine§  2.9 X 10  ~  3.9 ×  10  7 
* Medium conditioned for 48 h by P815 cells and dialyzed before use. 
:~ Mean ± SEM from three experiments. 
§ Data from one of two similar experiments. 
TABLE VI 
Effect of TCM on Macrophage Secretory Products Other Than ROI 
Secretory product  Macrophages 
Incubation medium* 
MEM-HS  TCM:~ 
Lysozyme§  Activated[[  137  106 
Plasminogen  activator¶  Activated  10.3  11.2 
Arachidonate**  Activated  11.8 --- 2.8  7.9 + 2.8 
Resident:~:~  38.3  34.6 
*  Macrophages were incubated for 48 h. Lysozyme  was measured at that time. Plasminogen activator was 
measured after a  further 48-h incubation in serum-free MEM. Arachidonate was measured after a 
further 24-h incubation in MEM-HS containing [ZH]arachidonic  acid. 
:~  Medium conditioned for 48 h by P815 cells and dialyzed. 
§  btg/mg cell protein. Means from three experiments. 
II  Elicited with sodium caseinate. 
¶  mU/mg cell protein (data from one of two similar experiments). 
** pmol//~g cell protein, including both arachidonic acid and its oxidized metabolites (means + SEM from 
four experiments). 
:~:~ From untreated mice (means from two experiments). ANNA  SZURO-SUDOL AND  CARL  F.  NATHAN  955 
small amounts of thymidine at a rate ~40% that of macrophages incubated in MEM- 
HS. Incorporation of methionine into protein was similar in both populations. 
Other Macrophage Secretory Products.  To determine whether TCM suppressed mac- 
rophage secretion nonspecifically, we compared the release of lysozyme, plasminogen 
activator, and  arachidonic  acid  products  from macrophages incubated  for 48  h  in 
TCM  or MEM-HS.  As shown  in Table VI, each substance was secreted in similar 
amounts from both cell populations.  It is of interest  that caseinate-activated macro- 
phages released less arachidonic  acid than  resident  cells, as has been observed with 
macrophages elicited by agents other than casein (57, 58). 
Discussion 
Mononuclear phagocytes undergo dramatic shifts in their capacity to secrete ROI 
as  they  differentiate.  Thus,  human  blood  monocytes  secrete  abundant  H202  in 
response to membrane stimulation.  As monocytes mature in vitro into larger,  more 
actively phagocytic cells, their ability to synthesize and secrete H202 wanes  (59,  60). 
H202-secretory capacity of human macrophages can be reinduced  by factors in the 
culture  medium  of stimulated  lymphocytes.  2 Similarly,  resident  peritoneal  macro- 
phages in the mouse resemble human monocyte-derived macrophages with regard to 
their low levels of H202  secretion  (24).  Under the influence of lymphokines in vitro 
(50, 52-54)  or the probable influence of antigen and antigen-specific T  lymphocytes 
in vivo (61), such tissue macrophages gradually acquire a capacity for H202 secretion 
similar to that of the blood monocytes from which they were derived (59). 
To  this  sequence  can  now  be  added  another  stage,  the  ability  of certain  cell- 
conditioned media, especially TCM, to induce a  gradual, profound, relatively selec- 
tive, nontoxic,  and slowly reversible deactivation of macrophage oxidative metabo- 
lism. Thus, a secretory product of tumor cells appears to influence the macrophage in 
a manner opposite to certain secretory products of lymphocytes, with nearly the same 
time course.  In our experiments, the suppressive effect of TCM  predominated over 
the stimulatory effect of lymphokines.  However, only a  limited  range of conditions 
was tested. 
A  principle suppressing macrophage H202-releasing capacity was detected  in  the 
culture  medium  of all  11  diverse  types  of tumors  tested,  as  well  as  in  medium 
conditioned  by diploid  fibroblasts, ovarian follicular cells, or an epithelial  cell line. 
Little  or  no  suppressive  activity  was  provided  by  the  medium  of erythrocytes  or 
macrophages, and variable amounts with spleen cells. The suppressive activity in the 
medium from nonmalignant  cells could be diluted out much more readily than that 
in TCM. In addition, suppression induced by nonmalignant cell-conditioned medium 
was reversible within 2 d, whereas that induced by TCM did not reverse within 4 d 
and began to reverse by the 6th d after its removal. Whether the suppressive activities 
of malignant  and nonmalignant  cells represent  different  amounts of the same sub- 
stance,  or  different  substances,  must  await  further  characterization  of the  active 
materials. 
Suppression of macrophage H202 release by TCM was recently described by Nelson 
et  al.  (62).  In that study, macrophages were only exposed overnight  to conditioned 
media, which  might explain why suppression was less  consistently observed than  in 
2 A. Nakagawara, N. M. DeSantis, N. Nogueira, and C. F. Nathan. Lymphokines enhance the capacity 
of human monocytes to secrete reactive oxygen intermediates.J.  Clin. Invest.  In press. 956  SUPPRESSION OF MACROPHAGE H202 RELEASE 
the present work. 
Thomas and Fishman (63) reported that tumor cells can interfere with the detection 
of H202 release from macrophages by competing for 02 during the assay. Interference 
by tumor cells in the H~O~ assay did not appear to be involved in our experiments, 
because the effects were seen with TCM in the absence of tumor cells; the TCM itself 
was  removed  before  the  assay;  and  similar  results  were  observed  using  a  different 
assay for superoxide anion. 
Some of the previously described effects of tumor cells on macrophages have been 
attributed to lactate dehydrogenase-elevating virus (13,  20). The P815  mastocytoma 
used for the majority of our experiments was shown to be free of this activity. Evidence 
of contamination  by  other  viruses  or  by  mycoplasma was  not  found.  The  factor 
suppressing  macrophage  oxidative  metabolism  passed  through  an  ultrafiltration 
membrane with a cutoff of 300,000 daltons, suggesting that the active factor is not a 
virus. However, further work is needed to compare the activity studied in the present 
report with  tumor-associated inhibitors  of macrophage morphologic polarization  in 
response  to  chemotactic  stimuli  (14).  These  inhibitors  appear  to  be  antigenically 
related to murine retroviruses (14). Tumor cells often secrete prostaglandins (64), and 
prostaglandins  can  impede  macrophage activation  as  measured  by HzO2-releasing 
capacity (65).  However, the active factor in TCM is not likely to be a prostaglandin, 
because it was nondialyzable and was inactivated by trypsin and boiling (unpublished 
observations). Further characterization of the suppressive factor is underway. 
Macrophages incubated in TCM appeared healthy and exhibited enhanced spread- 
ing often  associated with  "activation"  (55,  56).  They phagocytized starch  granules 
and synthesized protein at about the same rates as controls. Moreover, TCM-treated 
macrophages secreted three products at rates similar to control cells: lysozyme, whose 
release  from  macrophages  is  constitutive  and  not  much  affected  by  their  state  of 
activation (40); plasminogen activator, whose secretion is inducible and much greater 
from activated or inflammatory than  from resident  macrophages  (41);  and  arachi- 
donic  acid  and  its  oxygenated  metabolites,  which  are  also  secreted  in  response  to 
triggering stimuli, although  less  extensively from activated and  inflammatory mac- 
rophages than from resident cells (57,  58). We have not yet identified the individual 
arachidonate products secreted by TCM-treated macrophages, and therefore do not 
know what proportion of the released arachidonate  is oxygenated. Nonetheless,  it is 
noteworthy that arachidonic acid oxygenation constitutes a  respiratory burst similar 
in its elicitation and kinetics to that which produces ROI. The minimal effect of TCM 
on  the  secretion  of lysozyme, plasminogen  activator,  and  arachidonic  acid  and  its 
metabolites emphasizes the lack of toxicity of TCM and the relative specificity of its 
suppression of secretion of ROI. 
In preliminary experiments, TCM-treated macrophages were markedly suppressed 
in  their  ability  to  kill  certain  intracellular  protozoal  pathogens,  which  normally 
succumb to oxygen-dependent microbieidal processes within macrophages (H. Mur- 
ray, A. Szuro-Sudol,  and C. Nathan, manuscript in preparation). This suggests that 
levels  of ROI  were  diminished  not  only  extracellularly  but  also  intracellularly  in 
macrophages exposed to TCM. These experiments indicate further that the impaired 
respiratory burst of TCM-treated macrophages is manifest not only upon challenge 
with PMA or zymosan, but also in response to physiologically relevant stimuli. 
Transient suppression of macrophage oxidative metabolism by products of prolif- ANNA SZURO-SUDOL AND CARL F.  NATHAN  957 
crating  nonmalignant  cells,  such  as  fibroblasts,  might  benefit  the  host  during  the 
healing stages of inflammation. Macrophages could then phagocytize antibody-coated 
(66)  or  other  (67)  debris  without  releasing  ROI,  which  might  otherwise  damage 
nascent  fibroblasts  (68),  parenchymal  cells  (69),  endothelial  cells  (70),  or  ground 
substance (71).  Perhaps tumor cells exaggerate and exploit such a regulatory mecha- 
nism. Profound and long-lasting suppression of macrophage oxidative metabolism by 
tumor cells may help them escape cytotoxicity, while setting the stage for the growth 
of opportunistic microbial pathogens. 
Summary 
Each of 11 tumors tested produced a factor that markedly suppressed the ability of 
macrophages  to  release  H2Oe  or Oi-  in  response  to  phorbol  myristate  acetate  or 
zymosan. Four of seven normal cell types produced a similar activity, which was 3.5- 
7 times lower in titer than that in tumor cell-conditioned medium (TCM), and which 
was much more rapidly reversible in its effects. TCM caused 50% inhibition of H202 
release when  it was present  in  the  medium  for 48  h  at  a  concentration  of 13%,  or 
when  100% TCM was present in the medium for 18 h. The H202-releasing capacity 
of macrophages incubated  in TCM  only returned  to control  levels by 6  d  after its 
removal. TCM prevented augmentation of H202-releasing capacity by lymphokines. 
The  titer  of suppressive  activity  in  TCM  depended  on  both  the  concentration  of 
tumor cells and the duration of their incubation. TCM did not augment the activity 
of catalase, myeloperoxidase, glutathione peroxidase, or glutathione reductase or the 
content of glutathione within macrophages, suggesting that decreased synthesis rather 
than increased catabolism was responsible for reduced secretion of H202. Suppression 
of the release of H202 or Oi- by TCM appeared to be a  relatively specific effect, in 
that  TCM  increased  macrophage spreading and  adherence  to  glass while exerting 
little influence on rates of phagocytosis, synthesis of protein, or secretion of lysozyme, 
l~lasminogen activator, or arachidonic acid and its metabolites. Thus, tumor cells and 
some  normal  cells  can  secrete  a  factor  that  selectively  deactivates  macrophage 
oxidative metabolism. 
We are indebted to Z. A. Cohn for advice and critical review of the manuscript; C. Rouzer, W. 
Scott, and A. Hamill for help with arachidonate assays; M. Sudol for help with plasminogen 
activator assays and the epithelial cell line; B. Arrick and S. Strickland for advice; C. DeBoer, 
N.  DeSantis, and T. Overdank for expert technical assistance;  J. Adams for aid with figure 
preparation; and B. Broyles and L. LaPadula for preparation of the manuscript. 
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